Valuation: DBV Technologies

Market Cap 588M 648M 543M 490M 925M 60.54B 961M 6.55B 2.59B 32.67B 2.43B 2.38B 103B P/E 2026 *
-3.92x
P/E 2027 * -10.3x
Enterprise Value 487M 537M 450M 406M 767M 50.17B 796M 5.43B 2.15B 27.07B 2.01B 1.97B 85.53B EV / Sales 2026 *
145x
EV / Sales 2027 * 7.24x
Free-Float
99.85%
Yield 2026 *
-
Yield 2027 * -
1 day-3.69%
1 week-10.12%
Current month+6.06%
1 month+13.11%
3 months-29.84%
6 months-44.93%
Current year-46.66%
1 week 1.78
Extreme 1.781
2.18
1 month 1.53
Extreme 1.534
2.18
Current year 1.53
Extreme 1.534
4.4
1 year 1.53
Extreme 1.534
4.5
3 years 0.51
Extreme 0.506
4.5
5 years 0.51
Extreme 0.506
5.64
10 years 0.51
Extreme 0.506
86.64
Manager TitleAgeSince
Chief Executive Officer 66 2018-11-28
Director of Finance/CFO 56 2023-11-05
Chief Operating Officer - 2023-11-30
Director TitleAgeSince
Director/Board Member 51 2015-10-20
Director/Board Member 63 2016-06-20
Director/Board Member 60 2017-06-14
Date Insider Type Main position Quantity % Market Cap. Importance
7/29/26 Sell

Chief Technology Officer

-464 0.0002%
1/29/26 Sell

Chief Technology Officer

534 0.0003%
1/12/26
Baker Bros. Advisors LP
ExerciceCompany 54,609,792 27.1991%
Change 5-day change 1-year change 3-year change Capi.($)
-3.69%-10.12%-24.72%+6.62% 647M
-1.34%-1.15%+38.58%+139.28% 1,275B
-1.05%-0.37%+40.17%+86.76% 680B
-0.39%-0.30%+25.21%+111.85% 521B
-0.76%+1.10%+41.43%+70.96% 389B
-0.31%-2.75%+55.05%+41.50% 356B
-1.83%-0.89%+26.00%+58.48% 305B
-1.65%-0.59%+1.55%+34.52% 287B
-0.48%-1.20%+34.52%+73.20% 250B
+1.99%+0.04%+37.76%+126.57% 208B
Average -1.07%+0.01%+27.55%+74.97% 427B
Weighted average by Cap. -0.98%+0.76%+35.16%+95.88%

Financials

2026 *2027 *
Net sales 3.35M 3.69M 3.1M 2.79M 5.27M 345M 5.47M 37.31M 14.76M 186M 13.85M 13.56M 588M 64.94M 71.53M 59.99M 54.12M 102M 6.68B 106M 723M 286M 3.61B 268M 263M 11.39B
Net income -200M -220M -185M -167M -315M -20.57B -327M -2.23B -880M -11.1B -826M -809M -35.08B -143M -158M -132M -120M -226M -14.76B -234M -1.6B -631M -7.97B -593M -580M -25.17B
Net Debt -101M -111M -93.09M -83.98M -159M -10.37B -165M -1.12B -444M -5.6B -416M -408M -17.68B -118M -130M -109M -98.59M -186M -12.18B -193M -1.32B -521M -6.57B -489M -479M -20.76B
Projected Income Statement - Annual - DBV Technologies
Logo DBV Technologies
DBV Technologies specializes in developing solutions for diagnosing and treating food allergies (primarily to peanuts and cow's milk) using a patch (Viaskin®) that administers active ingredients into the top layers of the skin.
Employees
179
Date Price Change Volume
26-11-17 €1.803 -3.69% 838,222
26-11-16 €1.872 -4.83% 835,066
26-11-13 €1.967 -7.22% 1,258,036
26-11-12 €2.120 -0.66% 1,096,444
26-11-11 €2.134 +6.38% 1,681,461
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
MarketScreener Ratings - DBV Technologies
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
1.872EUR
Average target price
3.600EUR
Spread / Average Target
+92.31%